This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Alcon Research, Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Gregory Bydlinski: Innovator in Pharmaceutical Compositions
Introduction
Gregory Bydlinski is a notable inventor based in Kirkland, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the production of fluorescein. His work has implications for medical imaging and diagnostics.
Latest Patents
Bydlinski holds a patent for "Substantially Pure Fluorescein." This invention focuses on an improved process for producing substantially pure fluorescein, which is essential for pharmaceutical compositions used in angiography. The process results in fluorescein that is low in color, low in sodium chloride content, and substantially free of pyridine.
Career Highlights
Throughout his career, Gregory Bydlinski has worked with prominent companies in the pharmaceutical industry. He has been associated with Alcon Research, Ltd. and F.i.s. Fabbrica Italiana Sintetici S.p.a. His expertise in the field has allowed him to contribute to advancements in medical imaging technologies.
Collaborations
Bydlinski has collaborated with notable professionals in his field, including Robert G. Harris and Britt S. Scott. These collaborations have further enhanced his work and contributions to pharmaceutical innovations.
Conclusion
Gregory Bydlinski's work in developing substantially pure fluorescein showcases his innovative spirit and dedication to improving pharmaceutical compositions. His contributions have the potential to impact medical diagnostics significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile